Long-term oxygen therapy has been proven to improve survival in COPD patients with severely impaired oxygenation. However, does the COPD patient with moderately impaired oxygenation also benefit from supplemental long-term oxygen therapy? The Long-Term Oxygen Treatment Trial (LOTT), a randomized clinical trial published in 2016, was designed to evaluate the efficacy of supplemental oxygen for this patient population. This presentation will discuss the design and results of the multi-center LOTT and the implications on patient care.
This webcast is sponsored by an unrestricted educational grant from ResMed Inc.
View the Webcast and Earn CRCE Credit
View this webcast and take the accompanying test for CRCE Credit at AARC University ($9 for members, $18 for non-members). You will receive an email confirmation with full instructions after registering. Note that you will have to watch the entire webcast at AARC University to earn CRCE Credit.
View the Webcast—No CRCE Credit
This webcast is available for free without CRCE Credit.
